, Tracking Stock Market Picks
Enter Symbol:
Alnylam Pharmaceuticals, Inc. (ALNY) [hlAlert]

up 466.41 %

Alnylam Pharmaceuticals, Inc. (ALNY) rated Overweight with price target $184 by Piper Jaffray

Posted on: Monday,  Aug 31, 2015  10:25 AM ET by Piper Jaffray

Piper Jaffray rated Overweight Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) on 08/31/2015. Previously Piper Jaffray rated Overweight Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) on
12/12/2012., when the stock price was $18.52. Since then, Alnylam Pharmaceuticals, Inc. has gained 466.41% as of 01/22/2016's recent price of $104.90.
If you would have followed the previous Piper Jaffray's recommendation on ALNY, you would have gained 466.41% of your investment in 1136 days.

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi. The company is applying its therapeutic expertise in RNAi to address significant medical needs, many of which cannot effectively be addressed with small molecules or antibodies, the current major classes of drugs. Alnylam is building a pipeline of RNAi therapeutics; its lead program is in Phase I human clinical trials for the treatment of respiratory syncytial virus infection, which is the leading cause of hospitalization in infants in the U.S. The company's leadership position in fundamental patents, technology, and know-how relating to RNAi has enabled it to form major alliances with leading companies including Merck, Medtronic, Novartis, and Biogen Idec.

At Piper Jaffray, we understand there’s no substitute for relevant and timely research. That's why we provide: * fundamental and technical research * value-added investment ideas * market analysis With the information our research team provides, you’ll make better and more informed decisions for your portfolio.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/31/2015 10:25 AM Buy
105.48 184.00
as of 8/27/2015
1 Week down  -1.21 %
1 Month down  -20.18 %
3 Months down  -9.46 %
1 YTD up  63.14 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/12/2012 8:25 AM Buy
10/10/2007 9:25 AM Hold

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy